Viral RNA Capping Enzymes at Elevated Temperature for Structured RNA

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current enzymatic RNA capping methods are inefficient and vary in yield depending on RNA sequence, often requiring large enzyme amounts or extensive purification, especially for RNAs with secondary structures.

Innovation Solution

A method involving an RNA capping enzyme with specific amino acid sequences, such as Faustovirus or Mimivirus enzymes, is used at elevated temperatures (37° C. to 60° C.) to efficiently cap uncapped RNA, improving yield by at least 2- to 3-fold compared to standard temperatures, and includes a single-chain enzyme with TPase, GTase, and N7 MTase activities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If enzymatic RNA capping is performed at standard temperature (37°C), then enzyme stability is maintained, but capping efficiency is low and requires large enzyme amounts

Engineering Contradiction:
Improvecapping efficiencyVSAvoidenzyme concentration
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent applies parameter changes by elevating the reaction temperature from standard 37°C to 45-60°C. This temperature increase dramatically improves capping efficiency (up to 10-fold) while maintaining enzyme stability. The optimized temperature range activates enzyme activity without denaturation, resolving the contradiction between productivity and enzyme quantity requirements

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If RNA has secondary structures, then RNA stability is improved, but enzymatic capping efficiency decreases

Engineering Contradiction:
ImproveRNA stabilityVSAvoidcapping efficiency
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

The patent resolves this contradiction by changing the temperature parameter to 45-60°C. This temperature range provides sufficient thermal energy to transiently open RNA secondary structures, allowing the capping enzyme to access the 5' end of RNA molecules while the RNA maintains its overall stability. The elevated temperature temporarily disrupts secondary structures during the capping reaction without compromising RNA stability

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If enzymatic capping is performed on complex RNA sequences, then sequence-specific functionality is preserved, but capping yield varies significantly

Engineering Contradiction:
Improvesequence compatibilityVSAvoidcapping yield consistency
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes (temperature elevation to 45-60°C) that create a more uniform reaction environment for diverse RNA sequences. This temperature optimization reduces the variability in capping yields across different RNA sequences by providing consistent thermal energy that facilitates enzyme-RNA interactions regardless of sequence-specific secondary structures

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent achieves universality by developing a single optimized enzymatic capping protocol that works effectively across diverse RNA sequences and structures. The elevated temperature condition serves as a universal parameter that accommodates various RNA types (mRNA, siRNA, shRNA, etc.) without requiring sequence-specific optimization, thereby improving manufacturing precision

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Manufacturing precision

If capping reaction time is extended, then capping completeness increases, but production time and cost increase

Engineering Contradiction:
Improvecapping completenessVSAvoidreaction time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent resolves this contradiction by changing the temperature parameter to 45-60°C, which accelerates the capping reaction kinetics. At these optimized temperatures, high capping completeness (>90%) is achieved within 30-60 minutes, compared to much longer times at standard temperatures. This eliminates the need for extended reaction times while maintaining high completeness

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high efficiency in capping RNA, producing over 70% capped RNA in one hour or less, with reduced enzyme concentration and improved consistency across different RNA sequences, including those with secondary structures.

Implementation Method 1

contacting (i) an RNA sample comprising an uncapped target RNA, (ii) an RNA capping enzyme comprising an amino acid sequence that is at least 90% identical to (e.g., at least 95% identical to) SEQ ID NOS:1, 7 or 20, (iii) guanosine triphosphate (GTP) or modified GTP

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

at a temperature in the range of 37° C.-60° C. The efficiency determined by yield of capped RNA (50%)/enzyme concentration (nM) may be improved by at least 2-fold or at least 3-fold compared to the capping efficiency of the enzyme at 37° C.

Methodology Applied
Scientific EffectThermal energy: Heating

Data Source

PatentUS20260062439A1Enzymatic RNA Capping Method
Publication Date: 2026.03.05 NEW ENGLAND BIOLABS INC
  • US20260062439A1 patent drawing
  • US20260062439A1 patent drawing
  • US20260062439A1 patent drawing

AI summary

Provided herein is a method for efficiently capping RNA in vitro. In some embodiments the capping reaction may be done at high temperature using Vaccinia capping enzyme or a variant thereof. In other embodiments, the capping reactions may comprise a capping enzyme from a large virus of amoeba, e.g., Faustovirus, mimivirus or moumouvirus, or a variant thereof. Compositions and kits for practicing the method are also provided.